Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04370 | 33643422 | Evid Based Complement Alternat Med | Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis. | 2021 | Details |
| A04392 | 33637021 | Thyroid | Comparative Analysis of the Effects of Long-Term 3,5-diiodothyronine Treatment on the Murine Hepatic Proteome and Transcriptome Under Conditions of Normal Diet and High-Fat Diet. | 2021 | Details |
| A04400 | 33632710 | Gut | From the origin of NASH to the future of metabolic fatty liver disease. | 2021 | Details |
| A04414 | 33628193 | Front Pharmacol | Fructose and Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A04421 | 33622377 | Nutr Metab (Lond) | A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. | 2021 | Details |
| A04422 | 33622266 | BMC Gastroenterol | The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. | 2021 | Details |
| A04433 | 33618024 | Clin Gastroenterol Hepatol | Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults. | 2021 | Details |
| A04442 | 33615471 | J Cell Physiol | A new activator of esterase D decreases blood cholesterol level through ESD/JAB1/ABCA1 pathway. | 2020 | Details |
| A04457 | 33609166 | Abdom Radiol (NY) | Repeatability and accuracy of various region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification. | 2021 | Details |
| A04458 | 33608323 | Dis Model Mech | High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition. | 2021 | Details |
| A04468 | 33604250 | J Clin Transl Hepatol | Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04473 | 33603714 | Front Endocrinol (Lausanne) | Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery. | 2021 | Details |
| A04483 | 33600104 | Clin Transl Gastroenterol | Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study. | 2021 | Details |
| A04494 | 33596964 | J Med Case Rep | Hemochromatosis, alcoholism and unhealthy dietary fat: a case report. | 2021 | Details |
| A04501 | 33595790 | Obes Surg | Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review. | 2021 | Details |
| A04527 | 33586569 | Int J Food Sci Nutr | Reduced plasma carotenoids in individuals suffering from metabolic diseases with disturbances in lipid metabolism: a systematic review and meta-analysis of observational studies. | 2021 | Details |
| A04528 | 33586354 | ESC Heart Fail | Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT. | 2021 | Details |
| A04537 | 33584555 | Front Microbiol | The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study. | 2021 | Details |
| A04543 | 33584072 | World J Gastroenterol | Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy. | 2021 | Details |
| A04548 | 33582286 | Biochim Biophys Acta Mol Cell Biol Lipids | Chronic systemic exposure to IL6 leads to deregulation of glycolysis and fat accumulation in the zebrafish liver. | 2021 | Details |
| A04558 | 33580458 | Mol Biol Rep | Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model. | 2021 | Details |
| A04564 | 33578800 | Cancers (Basel) | Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma. | 2021 | Details |
| A04577 | 33574818 | Front Immunol | Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns. | 2021 | Details |
| A04586 | 33572544 | J Clin Med | Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition? | 2021 | Details |
| A04595 | 33569851 | J Gastroenterol Hepatol | Simple non-invasive scoring systems and histological scores in predicting mortality in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2021 | Details |
| A04599 | 33568418 | BMJ Open Gastroenterol | Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. | 2021 | Details |
| A04601 | 33567666 | Biomolecules | Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression. | 2021 | Details |
| A04613 | 33562473 | Biology (Basel) | Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04627 | 33558081 | Mol Genet Metab | US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score? | 2021 | Details |
| A04651 | 33551215 | Clin Nutr | Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A04653 | 33550587 | Hepatology | Heterogeneity of HSCs in a Mouse Model of NASH. | 2021 | Details |
| A04698 | 33536442 | Sci Rep | Clinical implications of renin-angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A04700 | 33535836 | Expert Rev Clin Pharmacol | An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapy. | 2021 | Details |
| A04731 | 33524747 | Chemosphere | Thiamethoxam induces nonalcoholic fatty liver disease in mice via methionine metabolism disturb via nicotinamide N-methyltransferase overexpression. | 2021 | Details |
| A04737 | 33520498 | Cureus | Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study. | 2020 | Details |
| A04753 | 33515021 | Nutr Rev | Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A04755 | 33514796 | Sci Rep | Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers. | 2021 | Details |
| A04756 | 33514365 | Cardiovasc Diabetol | Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study. | 2021 | Details |
| A04763 | 33513397 | Life Sci | The influence of PM2.5 exposure on non-alcoholic fatty liver disease. | 2021 | Details |
| A04772 | 33511140 | Front Med (Lausanne) | Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China. | 2021 | Details |
| A04776 | 33510172 | Nat Commun | CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis. | 2021 | Details |
| A04778 | 33509389 | Lancet Digit Health | Screening and identifying hepatobiliary diseases through deep learning using ocular images: a prospective, multicentre study. | 2021 | Details |
| A04784 | 33505944 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. | 2021 | Details |
| A04785 | 33505943 | Can J Gastroenterol Hepatol | Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications. | 2021 | Details |
| A04798 | 33503814 | Int J Mol Sci | Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2. | 2021 | Details |
| A04800 | 33501884 | Am J Physiol Gastrointest Liver Physiol | Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization. | 2021 | Details |
| A04803 | 33500717 | Theranostics | Intravital imaging of interactions between iNKT and kupffer cells to clear free lipids during steatohepatitis. | 2021 | Details |
| A04808 | 33498493 | J Clin Med | The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver. | 2021 | Details |
| A04815 | 33496858 | J Gastroenterol | Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database. | 2021 | Details |
| A04817 | 33495844 | Mol Med Rep | Effects of renalase deficiency on liver fibrosis markers in a nonalcoholic steatohepatitis mouse model. | 2021 | Details |
| A04821 | 33493692 | Clin Gastroenterol Hepatol | Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States, 2011-2018. | 2021 | Details |
| A04830 | 33491316 | Obesity (Silver Spring) | Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04834 | 33490623 | JGH Open | Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis. | 2020 | Details |
| A04839 | 33488526 | Front Endocrinol (Lausanne) | Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. | 2021 | Details |
| A04843 | 33486773 | Hepatology | Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. | 2021 | Details |
| A04854 | 33482026 | Aliment Pharmacol Ther | Cross-linkage between bacterial taxonomy and gene functions: a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease. | 2021 | Details |
| A04869 | 33474981 | AJR Am J Roentgenol | Utility of Multiparametric CT for Identification of High-Risk NAFLD. | 2021 | Details |
| A04877 | 33470860 | Expert Opin Investig Drugs | A perspective on RNA interference-based therapeutics for metabolic liver diseases. | 2021 | Details |
| A04884 | 33467546 | Int J Mol Sci | Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. | 2021 | Details |
| A04903 | 33458794 | Metabolomics | Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. | 2021 | Details |
| A04913 | 33453067 | Liver Int | From NAFLD to MAFLD: Nurse and allied health perspective. | 2021 | Details |
| A04920 | 33449180 | Eur Radiol | CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF. | 2021 | Details |
| A04925 | 33446707 | Sci Rep | The potential ameliorative impacts of cerium oxide nanoparticles against fipronil-induced hepatic steatosis. | 2021 | Details |
| A04928 | 33446095 | BMC Geriatr | Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study. | 2021 | Details |
| A04931 | 33445719 | Int J Environ Res Public Health | Mortality Risk and Decompensation in Hospitalized Patients with Non-Alcoholic Liver Cirrhosis: Implications for Disease Management. | 2021 | Details |
| A04942 | 33442446 | World J Hepatol | Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. | 2020 | Details |
| A04950 | 33439540 | J Gastroenterol Hepatol | The impact of sodium glucose co-transporter 2 inhibitors on non-alcoholic fatty liver disease. | 2020 | Details |
| A04958 | 33437901 | Hepatol Commun | Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04973 | 33431890 | NPJ Vaccines | Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A04975 | 33431715 | Gut Liver | Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
| A04980 | 33428035 | Dig Dis Sci | Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value. | 2021 | Details |
| A04982 | 33426569 | J Med Syst | Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. | 2021 | Details |
| A04984 | 33425805 | Can J Gastroenterol Hepatol | Diospyros kaki and Citrus unshiu Mixture Improves Disorders of Lipid Metabolism in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04991 | 33422007 | BMC Gastroenterol | Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study. | 2021 | Details |
| A04994 | 33421884 | Eur J Radiol | The clinical utility of accurate NAFLD ultrasound grading: Results from a community-based, prospective cohort study. | 2021 | Details |
| A05006 | 33414764 | Front Endocrinol (Lausanne) | FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human. | 2020 | Details |
| A05007 | 33413363 | Cardiovasc Diabetol | Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. | 2021 | Details |
| A05022 | 33408299 | J Toxicol Sci | Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase. | 2021 | Details |
| A05024 | 33407169 | BMC Gastroenterol | Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis. | 2021 | Details |
| A05033 | 33400995 | Transl Res | The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology. | 2021 | Details |
| A05037 | 33398776 | Hepatol Int | Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice. | 2021 | Details |
| A05061 | 33390956 | Front Pharmacol | Hydrogen Sulfide Attenuates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Inhibiting Apoptosis and Promoting Autophagy via Reactive Oxygen Species/Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Signaling Pathway. | 2020 | Details |
| A05062 | 33390939 | Front Pharmacol | Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice. | 2020 | Details |
| A05065 | 33389543 | Rev Endocr Metab Disord | Lean NAFLD: an underrecognized and challenging disorder in medicine. | 2021 | Details |
| A05066 | 33389416 | Dig Dis Sci | A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05069 | 33388475 | Prostaglandins Leukot Essent Fatty Acids | Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease. | 2020 | Details |
| A05074 | 33387126 | Dig Dis Sci | Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis. | 2021 | Details |
| A05120 | 33368494 | J Clin Periodontol | Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults. | 2021 | Details |
| A05133 | 33361348 | Gut | RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. | 2020 | Details |
| A05141 | 33358553 | Ultrasound Med Biol | Use of a convolutional neural network and quantitative ultrasound for diagnosis of fatty liver. | 2020 | Details |
| A05150 | 33353230 | Nutrients | Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet. | 2020 | Details |
| A05181 | 33345307 | Hepatology | Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. | 2021 | Details |
| A05190 | 33341674 | Biochem Biophys Res Commun | Hepatocyte-specific TAZ deletion downregulates p62/ Sqstm1 expression in nonalcoholic steatohepatitis. | 2020 | Details |
| A05195 | 33340780 | Clin Gastroenterol Hepatol | Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05226 | 33332766 | Immun Inflamm Dis | Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. | 2020 | Details |
| A05249 | 33324348 | Front Endocrinol (Lausanne) | Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. | 2020 | Details |
| A05266 | 33319459 | Liver Int | Metabolic-associated fatty liver disease (MAFLD) in coeliac disease. | 2020 | Details |
| A05282 | 33313020 | Can J Gastroenterol Hepatol | Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: "Un Affaire de Coeur". | 2020 | Details |
| A05293 | 33310185 | Biochem Biophys Res Commun | Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis. | 2020 | Details |
| A05305 | 33307138 | J Hepatol | Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. | 2020 | Details |